Director, Products & Business Development, Solid Tumors

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and Med Tech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at  As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Job Function:
Strategy & Corporate Development Job Sub Function:
Business Development Job Category:
Professional All Job Posting Locations:
Horsham, Pennsylvania, United States of America

Job Description:

Johnson & Johnson is recruiting for a Director, New Products & Business Development, Solid Tumors, to be located in Horsham, PA.

About Oncology Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Our Oncology team is focused on the elimination of cancer by discovering new pathways and modalities to finding treatments and cures. We lead where medicine is going and need innovators with an unwavering commitment to results.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at

The Director, New Products & Business Development will enable US market readiness and shape go-to-market strategies for priority Oncology Solid Tumor assets and precision medicine opportunities. This role will represent the US market in global discussions and provide commercial input on compound strategy, positioning, trademark and branding, and key pre-launch initiatives.

• US Readiness & Go-to-Market Strategy:
  Lead development and execution of robust go-to-market strategies to ensure US readiness for new Oncology Solid Tumor assets. Define launch readiness priorities, critical milestones, and decision points across pre-launch planning. Translate asset strategy into practical launch planning implications for the US market.
• Global Representation & Compound Strategy:
  Represent the US market in global forums and provide strategic input on compound strategy, positioning, trademark and branding, and key pre-launch initiatives. Ensure US customer, marketplace, and competitive considerations are reflected in global decision-making.
• Strategic Planning & Market Shaping:
  Drive US strategic planning, including positioning, value proposition development, and input into US label planning to align with market needs. Develop and implement early market-shaping strategies, including unbranded market development, evidence generation, and Key Opinion Leader engagement.
• Commercial Insight Integration:
  Ensure commercial insights inform clinical development plans, competitive vision, Target Product Profile, and value proposition for products progressing through investment governance. Partner with Analytics to develop customer-insight-based forecasts and valuations that guide stage-gate decisions.
• Business Development Support:
  Lead US input on selected Business Development opportunities, including competitive landscape assessment, opportunity identification, and prioritization of required product attributes. Provide clear US commercial perspective to support…